March 30, 2021
Ohara Pharmaceutical said on March 29 that it has filed a new drug application in Japan for glucarpidase (OP-07) for the treatment of methotrexate (MTX) toxicity. The drug, an enzyme that hydrolyzes MTX, was granted orphan designation in August last...read more